Craig C. Hopkinson, EVP R&D, Chief Medical Officer at Alkermes plc., sold ALKS on Sep 1, 2026
Data as of Oct 16
▼ SELL$423K9,000 shares at $46.99Craig C. Hopkinson EVP R&D, Chief Medical OfficerALKS Alkermes plc.
- Traded
- Sep 1, 2026
- Disclosed
- Sep 1, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ALKS since disclosure
−12.7%
after the sale
Similar stocks (XLV) since disclosure
+2.9%
XLV — its sector index fund
Change in closing price from Sep 1, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.